Two Sigma Investments, LP Inovio Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.35 - $0.53 $175,052 - $265,079	-500,150 Reduced 60.31%	329,088 $167,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $368,220 - $562,021	-969,002 Reduced 53.89%	829,238 $323,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $701,313 - $1.69 Million	1,798,240 New	1,798,240 $809,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $2.08 Million - $3.69 Million	-1,475,869 Reduced 77.74%	422,525 $659,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $4.45 Million - $7.48 Million	-2,681,242 Reduced 58.55%	1,898,394 $3.28 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $3.23 Million - $8.92 Million	2,241,221 Added 95.84%	4,579,636 $7.92 Million
Q1 2022 May 16, 2022	BUY	$2.97 - $5.2 $6.95 Million - $12.2 Million	2,338,415 New	2,338,415 $8.4 Million
Q1 2020 May 15, 2020	SELL	$2.98 - $14.09 $455,957 - $2.16 Million	-153,006 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.97 - $3.72 $268,670 - $507,337	136,381 Added 820.34%	153,006 $505,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $214,749 - $316,363	-104,756 Reduced 86.3%	16,625 $34,000
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $29,740 - $53,246	-12,987 Reduced 9.67%	121,381 $357,000
Q1 2019 May 15, 2019	SELL	$3.34 - $5.1 $135,907 - $207,524	-40,691 Reduced 23.24%	134,368 $501,000
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $95,604 - $150,165	24,577 Added 16.33%	175,059 $700,000
Q3 2018 Nov 14, 2018	SELL	$3.92 - $5.58 $98,497 - $140,208	-25,127 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $97,492 - $129,655	25,127 New	25,127 $98,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $544M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.